Ionis provides update on development program evaluating PCSK9 antisense medicine ... - BioSpace

Retrieved on: 2022-09-23 07:38:53

Tags for this article:

Lipids

Branches of biology

Spinal muscular atrophy

Antisense RNA

Medical specialties

Huntington's disease

Ionis Pharmaceuticals

PCSK9

Lipid metabolism disorders

Low-density lipoprotein

Ionis

Statin

Ionis Pharmaceuticals Inc

Click the tags to see associated articles and topics

Ionis provides update on development program evaluating PCSK9 antisense medicine ... - BioSpace. View article details on HISWAI: https://www.biospace.com/article/releases/ionis-provides-update-on-development-program-evaluating-pcsk9-antisense-medicine-for-the-treatment-of-hypercholesterolemia/

Excerpt

AstraZeneca licensed ION449 from Ionis in 2015. About Hypercholesterolemia. Hypercholesterolemia, or elevated LDL-C levels in the blood, is an ...

Article found on: www.biospace.com

View Original Article